Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
about
The progress of angiogenic factors in the development of leukemiasMolecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerNon-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesisThe anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.The lymphatic system and pancreatic cancer.Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemanDiscovery of Potent c-MET Inhibitors with New Scaffold Having Different Quinazoline, Pyridine and Tetrahydro-Pyridothienopyrimidine Headgroups.Effects of CASP5 gene overexpression on angiogenesis of HMEC-1 cells.Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma.Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1
P2860
Q26753835-430FA105-3710-4CA0-8ECF-11E3E7D914E8Q26774636-61741DCA-D3A3-4DF3-B520-72BC0861CDA6Q28067777-6C763C20-6E19-4DF5-8862-64A3A2E13597Q35995835-4708C950-E698-4C27-809E-B52B200EB10EQ37034926-0779E13C-2995-4851-A49A-16A8FC087130Q37109919-756882BC-4911-48AF-8CA1-C73D161ADF48Q38689578-A906F009-1115-4E45-9A5F-E9A394D1E2E2Q38758443-DE2A833E-6496-40D9-807E-48EE0F369B14Q38770450-CD1BA804-9205-475D-89DD-B8B112F8B5B8Q38793575-6F9230D3-4C85-4E7E-B3F0-4A048E006ABDQ42363709-E89C42E4-7B26-4359-BDF3-F0BB75C53B30Q49887930-D91B017F-71EB-4B94-832B-BBA69095CFD9Q58701870-66C8A382-7829-4679-B934-4C7BE2D5688A
P2860
Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@ast
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@en
type
label
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@ast
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@en
prefLabel
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@ast
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@en
P2093
P2860
P356
P1433
P1476
Foretinib inhibits angiogenesi ...... VEGFR-2/3 and TIE-2 signaling.
@en
P2093
Chia-Hua Tsai
Hsiu-Mei Chen
Wen-Chun Hung
P2860
P304
14940-14952
P356
10.18632/ONCOTARGET.3613
P407
P577
2015-06-01T00:00:00Z